Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07238192 · ClinicalTrials.gov registry record · NA

Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD

A NA study of Suicidal Ideation and Posttraumatic Stress Disorder (PTSD), sponsored by Ohio State University.

Recruiting
Registry status
NA
Development phase
190
Enrollment target
1
Study location

NCT07238192: Recruiting NA study of Suicidal Ideation and Posttraumatic Stress Disorder (PTSD), sponsored by Ohio State University.

NCT07238192 is a NA study of Suicidal Ideation and Posttraumatic Stress Disorder (PTSD) that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 190 participants, below the 266-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07238192, a NA study of Suicidal Ideation and Posttraumatic Stress Disorder (PTSD), is actively recruiting participants, sponsored by Ohio State University.

RECRUITING
Registry status
NA
Development phase
190 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to see if Crisis Response Planning (CRP), a brief strategy designed to help people cope effectively with emotional crises, combined with Cognitive Processing Therapy (CPT), a talk treatment for posttraumatic stress disorder (PTSD), will reduce suicidal thoughts and behaviors.

Primary Outcome

The PTSD Checklist for the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (PCL-5) is a 20-item self-report measure used to assess PTSD symptom severity and monitor clinical change over time. Each item is rated on a 5-point scale (0 = Not at all to 4 = Extremely), yielding a total score ranging from 0 to 80, with higher scores indicating worse PTSD symptom severity.

Interventions

  • BEHAVIORAL Cognitive Processing Therapy

Study Locations (1)

Texas

  • Carl R. Darnall Army Medical Center - Fort Hood

Trial Details

FieldValue
Enrollment Target 190 participants
Start Date 2026-01-28
Est. Completion 2028-08-31
Phase NA
Ohio State University

552 total trials

What NCT07238192 shows while recruiting

NCT07238192 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 266-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (29% lower).

The record links to 3 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Processing Therapy is the first listed.

NCT07238192 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT07238192 about?

NCT07238192 is a clinical study titled "Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD". The purpose of this research is to see if Crisis Response Planning (CRP), a brief strategy designed to help people cope effectively with emotional crises, combined with Cognitive Processing Therapy (CPT), a talk treatment for posttraumatic stress disorder (PTSD), will reduce suicidal thoughts and be...

What is the current status of trial NCT07238192?

This trial is currently recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2026-01-28. Estimated completion is 2028-08-31.

What conditions does trial NCT07238192 study?

This clinical trial studies the following conditions: Suicidal Ideation, Posttraumatic Stress Disorder (PTSD), Suicide Attempt.

What interventions are being tested in trial NCT07238192?

The interventions under investigation include: Cognitive Processing Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT07238192?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07238192 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07238192's enrollment target sits among peer trials

190 30th of 84 higher than 55 of 84 other Suicidal Ideation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03257033 · 190 participants · Phase 3

    Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

  • NCT03642028 · 190 participants · Phase 4

    Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress

  • NCT04015609 · 190 participants · NA

    Psychotherapy Intervention for Latinos With Advanced Cancer

  • NCT04284397 · 190 participants · Early Phase 1

    Identification of Critical Thermal Environments for Aged Adults

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07238192, the US trial registry maintained by the National Library of Medicine. NCT07238192 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.